BioMarin to Participate in Two Upcoming Virtual Investor Conferences

Rhea-AI Summary

BioMarin Pharmaceutical announced participation in two virtual investor conferences on February 16, 2022. The management will present, and a live audio webcast of the presentations can be accessed at the official website. An archived version will also be available after the events. BioMarin, focusing on innovative therapies for serious rare disorders, has a diverse portfolio with seven commercial products. For more details, visit www.biomarin.com.

SAN RAFAEL, Calif., Feb. 16, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in two upcoming virtual conferences.  An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:
Investors	Media
Traci McCarty	Debra Charlesworth
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(415) 455-7451

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-two-upcoming-virtual-investor-conferences-301484038.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

What are the dates of the upcoming virtual conferences for BioMarin (BMRN)?

The virtual conferences are scheduled for February 16, 2022.

How can I access the audio webcast of BioMarin's presentations?

You can access the audio webcast at the official BioMarin website.

What is the focus of BioMarin Pharmaceutical's work?

BioMarin develops therapies for serious and life-threatening rare disorders.

How many commercial products does BioMarin have?

BioMarin has seven commercialized products.

Where can I find more information about BioMarin Pharmaceutical (BMRN)?

More information is available on BioMarin's website at www.biomarin.com.